Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |